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Abstract 
This theme issue provides an overview on recent developments of light-mediated imaging and 
therapy approaches, with an emphasis on those that transcend the shallow tissue penetration 
dogma. 
Key words: tissue penetration, theranostics, nanoparticles, photodynamic therapy, photothermal therapy 
 
Light-mediated imaging and therapy has been 
widely investigated in pre-clinical studies, especially 
for cancer related applications. However, the clinical 
utility of the techniques has been rather limited. While 
the causes may be multifold, a common impediment 
is the shallow penetration of light. When light hits 
body tissues, a majority of the photons are scattered 
or absorbed. This restricts the penetration of light to 
one centimeter or less, limiting the applications of 
light-mediated approaches to superficial positions. 
Due to this reason, many imaging and therapy 
procedures, while perfectly demonstrated in small 
animals, are regarded as of limited clinical relevance.  
Recent advances in materials science, 
nanotechnology, engineering, and light delivery has 
led to breakthroughs that may transcend the 
limitation. For instance, scientists have developed 
novel optimal nanomaterials, which, unlike 
conventional fluorophores, emit in the second 
near-infrared window (1100-1400 nm), where tissue 
absorbance and scattering is at the minimum. 
Progress has also been made in developing 
energy-converting phototherapies that allow X-ray, 
Cherenkov radiation, ultrasound, or microwaves to 
indirectly activate a photodynamic therapy (PDT) or 
photothermal therapy (PTT) procedure, again with 
the objective of breaking the shallow penetration 
dogma. Moreover, new imaging methodologies, such 
as photoacoustic imaging (PAI), persistent 
luminescence imaging, chemiluminescence resonance 
energy transfer imaging, Cherenkov luminescence 
imaging, and X-ray-induced optical luminescence 
imaging, have been developed and investigated. 
Furthermore, there have also been efforts of bringing 
together advances from more than one front to 
achieve combination therapy or theranostics, often in 
the form of novel multiple nanoplatforms.  
In this special issue, we invite experts worldwide 
to share with us cutting-edge developments in 
light-mediated imaging and therapy. These include 
techniques that are developed to improve the 
efficiency or accuracy of light-mediated therapy at a 
deep tissue position. For instance, Xie et al. 
demonstrated that with MC540-SrAl2O4:Eu@SiO2 
nanoparticles, PDT can be activated from beneath 
thick tissues with X-ray irradiation [1]. This 
methodology, referred to as X-ray induced 
photodynamic therapy (X-PDT), breaks the shallow 
tissue penetration dogma of conventional PDT and 
may find wide applications in modern oncology. The 
authors also showed that X-PDT is more than just a 
PDT derivative but rather a PDT and RT combination, 
which explains the excellent treatment efficacy 
observed with the new modality. Kohane et al. 
developed a theranostic nanoplatform consisting of a 
gold nanostar (AuNS) core, and a shell of 
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coordination polymer (CP) tethered with gadolinium 
and gemcitabine monophosphate [2]. These 
AuNS@CP nanoparticles afforded high T1 contrast, 
strong two-photon photoluminescence (TPL), good 
gemcitabine loading capacity, and excellent 
photothermal effect. Impressively, their migration in 
vivo not only can be monitored by MRI, but also by 
intravital TPL at the microscopic level, allowing for 
precise photothermal- and chemo- combination 
therapy. Mohs et al. synthesized a panel of hyaluronic 
acid (HA) based nanoparticles that were either 
physically entrapped with indocyanine green (ICG) or 
covalently conjugated with Cy7.5 [3]. These 
formulations were evaluated as intraoperative optical 
imaging agents for accurate tumor removal. 
We also want to highlight several studies that 
attempt to develop smart nanoplatforms responsible 
for light-based cues. For instance, Lovell et al. reported 
a novel porphyrin–phospholipid (PoP) liposome that 
can encapsulate anti-cancer agents and release them 
under near-infrared (NIR) irradiation in a controlled 
manner [4]. The authors were able to monitor the 
drug release in vivo by intravital microscopy (IVM) 
and they confirmed the great treatment efficacy of the 
approach in MIA Paca-2 tumor bearing mice. Zheng et 
al. prepared a smart DOX/IR-780-co-loaded 
temperature-sensitive-liposome (DITSL), in which 
IR-780 was incorporated into the 
temperature-sensitive lipid bilayer and doxorubicin 
(DOX) into the hydrophilic core [5]. Under 808 nm 
irradiation, DITSL showed controlled drug release, 
enabling combination photothermal- and chemo- 
therapy against cancer. Cui et al. introduced a 
mitochondria-targeting drug delivery system, 
ZnPc/CPT-TPPNPs [6]. These nanoparticles can 
preferentially accumulate in mitochondrion of a cell 
and, under photo-irradiation, produce reactive 
oxygen species (ROS) to damage the organelle. 
Meanwhile, the yielded ROS also facilitated the 
release of camptothecin, which is a topoisomerase I 
inhibitor targeting nucleus DNA. Jon et al. reported a 
new nanomedicine designated as SP3NPs, which can 
simultaneously mediate PDT and PTT [7]. In vivo 
experiments showed that SP3NPs can preferentially 
accumulate in tumors after systemic injection, 
mediating imaging-guided combination PDT/PTT for 
efficient tumor eradication.  
The special issue also includes several timely 
review articles. For instance, Hasan et al. overviewed 
recent advances and new strategies that aim at 
increasing the ‘damage zone’ of PDT beyond the 
reach of light in the body [8]. Richard et al. reviewed 
developments on nanoprobes with persistent 
luminescence properties [9]. Unlike conventional 
fluorophores, these persistent luminescence 
nanoprobes can emit photons at the absence of 
excitation light, linking to small background 
interference and deeper imaging depth. Han et al. 
reviewed recent progress on synthesizing calcium 
fluoride based upconversion nanoparticles and their 
use as novel nanoagents in cancer imaging and 
therapy [10]. Huang et al. summarized developments 
in PAI, which affords good contrast, high resolution, 
and deep tissue penetration [11]. Meanwhile, Chu et 
al. reviewed progress on developing genetically 
encoded probes for PAI, with an emphasis on 
BphP1-based tags [12]. Compared with molecule or 
nanoparticle based PAT probes, genetically encoded 
ones afford advantages including facile labeling of 
cells and protein targets and good in vivo stability. 
Wang wrote a nice overview on IVM, with a focus on 
its applications in nanomedicine developments [13]. 
IVM is an emerging imaging tool that can be used to 
study living subjects under physiological conditions 
at high spatial and temporal resolutions. Finally, Xing 
et al. summarized light-triggered theranostic 
strategies, including those based on Cerenkov 
radiation, and discussed current challenges and 
future perspectives [14].  
In summary, light-mediated imaging and 
therapy has made tremendous progress in the past 
decade but the clinical translation of the approaches 
had been hampered by the relatively shallow 
penetration of light. With emerging nanomaterials, 
engineering techniques, and novel strategies that 
address the issue, it is expected that many of the 
light-mediated approaches will be brought forward 
and eventually make an impact in the clinic. 
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